The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise
Background While a range of interventions exist for tuberculosis prevention, screening, diagnosis, and treatment, their potential population impact and cost-effectiveness are seldom directly compared,...
At a time when global resources for #TB research, development, prevention, and care are limited, which interventions should be prioritised in high burden settings?
📢 Our new pre-print compares the impact, cost, and cost-effectiveness of 9 TB interventions in 3 countries. 1/n
bit.ly/3V3vXth
05.09.2025 10:05 — 👍 11 🔁 9 💬 1 📌 0
Secretary of State Marco Rubio has imposed sanctions on Francesca Albanese, the U.N. special rapporteur on the occupied Palestinian territory.
Albanese says the move is an effort to “distract” from the genocide in Gaza.
10.07.2025 14:13 — 👍 442 🔁 158 💬 14 📌 18
New systematic review led by @hannahrickman.bsky.social shows annual risk of Mycobacterium #tuberculosis conversion in men and women diverges during adolescence and remains higher among men throughout adulthood.
www.thelancet.com/journals/lan...
02.07.2025 14:57 — 👍 5 🔁 6 💬 0 📌 0
Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.
In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.
doi.org/10.1016/S221...
@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
04.07.2025 11:25 — 👍 14 🔁 14 💬 3 📌 0
The facts are simple and devastating: Aid cuts have already cost lives, and the number of deaths will continue to rise. Here’s the evidence.
03.07.2025 23:21 — 👍 2698 🔁 728 💬 142 📌 41
Palestinians fleeing northern Gaza on 9 November 2023 amid Israel's bombardment and siege of the enclave, and intense fighting between the Israeli military and Hamas fighters in the north. Credit: Mohammed Zaanoun/TNH
LSHTM's Director writes to UK Government about #Gaza public health catastrophe
Professor Liam Smeeth's letter to the Prime Minister & Foreign Secretary urges action to prevent a greater #PublicHealth disaster:
👉 www.lshtm.ac.uk/newsevents/n...
20.06.2025 13:32 — 👍 27 🔁 19 💬 0 📌 3
Amid all the bad news in Global Health, perhaps some good news? A first analysis on the risk of false positive diagnoses in community-screening for tuberculosis using Xpert shows our clinic-based data is likely (very) wrong and overestimates false positives by >80%: tinyurl.com/yfecute9.
27.05.2025 14:50 — 👍 25 🔁 10 💬 3 📌 1
Postdoc (London, UK)
Position available in the world-leading tuberculosis (TB) Modelling group at LSHTM
with @raclark18.bsky.social @richardwhite321.bsky.social
at LSHTM @lshtm-tbmod.bsky.social
More details: http://iddjobs.org/jobs/2314
20.05.2025 19:07 — 👍 6 🔁 7 💬 0 📌 0
Climate change and tuberculosis: an analytical framework
Climate change is likely to exacerbate a range of determinants which drive tuberculosis, the world's leading infectious disease killer. However, tuberculosis is often neglected in wider climate health...
Climate change is likely to exacerbate determinants which drive TB, the world’s leading infectious disease killer. Commissioned by WHO, we developed an analytical framework outlining potential causal relationships between climate change and TB:
medrxiv.org/cgi/content/...
@lshtm.bsky.social @who.int
21.02.2025 09:30 — 👍 18 🔁 13 💬 1 📌 2
PhD position (London, UK)
Quantify the effects of climate change on TB
with @cfmcquaid.bsky.social @reinhouben.bsky.social @laragosce.bsky.social
at @cmmid-lshtm.bsky.social @tb-lshtm.bsky.social @lshtm.bsky.social
More details: http://iddjobs.org/jobs/2253
07.02.2025 19:23 — 👍 2 🔁 7 💬 0 📌 0
Reflecting on this year’s #TB #UnionConf2024 and am so inspired by the brilliant minds and groundbreaking research being done to combat this global health threat. Special shoutout to the TB Modelling Group @lshtm.bsky.social 🫁
17.11.2024 19:56 — 👍 19 🔁 5 💬 2 📌 2
Public health physician and social epidemiologist passionate about addressing inequities in health and wellbeing through practice, research, and advocacy https://www.researchgate.net/profile/Matthew-Saunders-3?ev=hdr_xprf
Epidemiologist @uclglobalhealth.bsky.social & @ahri-news.bsky.social. Focus on data collection, social networks & health (HIV, mental health, caregiving, vaccines). Mostly in southern Africa.
We’re the European Centre for Disease Prevention and Control. We aim to strengthen EU’s defences vs infectious diseases. Here to promote public health.
PhD Candidate @Radboudumc | Tuberculosis | Epidemiology
The Global TB Program at Texas Childrens and @bcmhouston.bsky.social focuses on #TB prevention, diagnostics, treatment, & immunology under the direction of Dr @annamandalakas.bsky.social #TBSky
Centre for Mathematical Modelling of Infectious Diseases at @lshtm.bsky.social
News and expert comment from the London School of Hygiene & Tropical Medicine (LSHTM). Celebrating 125 years as one of the world's leading #PublicHealth universities. https://linktr.ee/lshtm
We (The World Health Organization) are the United Nations’ health agency championing Health For All. Always check the latest posts for updated advice/information. We will remove misinformation, spam, and hate speech here.
Prof Operational Research , @UCL_CORU, passionate about health care, women in STEMs, defending liberal democracy (!). Member of @independentsage, posts personal. https://www.trumpactiontracker.info/
Professor of Infectious Disease Epidemiology @lshtm.bsky.social Opinions mine, re-posts not endorsements.
Pediatric infectious disease doc | global health researcher | modelling disease burden and intervention coverage from local to global scales | #vaccines, #VPDs, #NTDs, #malaria, #anemia, #hemoglobinopathies, #geospatial analysis | he/him | opinions my own
Infectious disease modeller. Lecturer in stats at University of Bristol.
Assistant Professor NUS. Infectious diseases, virus evolution, AI for Public Good, Human Behaviour and Bayesian Inference
Fritz Family Postdoctoral fellow in Epidemiology at Georgetown University | infectious disease modeling.
My website: https://giuliapullano.weebly.com/
Lecturer and Eric and Wendy Schmidt AI in Science Fellow @mrc-outbreak.bsky.social @ Imperial College London. Mathematical modelling of malaria, COVID-19 & humanitarian response.
Phylo, dynamics, epidemiology, data sci, computational biology
University of Auckland
PhD candidate at Wageningen University and Research | Viral modeler 🦠🖥️ | Interested in anticipating future outbreaks of infectious diseases 🔮
Associate Professor at University of Washington, Seattle.
Demographer who studies Pop Health, Pop Environment, and Infectious disease dynamics. Data Visualization Enthusiast. 🇭🇹
Infectious disease modeller
Main interest in aborvirures
Public Health Analytics and Modeling fellow at CDC
Working at the dengue branch, San Juan, Puerto Rico